http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011152516-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e019980e0d3964666d42b84f16f7fe2a
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-13
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D498-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-437
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D498-22
filingDate 2011-03-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c9ad55316e2e879628faf820a1ed4a7a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d4e9e33d6a2bf3900ce310d96af53953
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_440d8aa2e202b1e35db13890fd21b7ba
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b56cf192512abb19e6cbf4c71c227ac9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_54d860e044c276002c594bf735ced46c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_073b3e962e2c500de1987796ca7d3fe9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bbe003f16638b16b5f4d68afa0548941
publicationDate 2011-06-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2011152516-A1
titleOfInvention Pharmaceutical compositions comprising polymorphic forms alpha, beta, and gamma of rifaximin
abstract Crystalline polymorphous forms of rifaximin (INN), referred to as rifaximin α and rifaximin β, and a poorly crystalline form referred to as rifaximin γ, useful in the production of medicaments containing rifaximin for oral and topical use and obtained by means of a crystallization process carried out by hot-dissolving the raw rifaximin in ethyl alcohol and by causing the crystallization of the product by addition of water at a fixed temperature and for a fixed period of time, followed by a drying under controlled conditions until reaching a precise water content in the end product, are the object of the invention.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8518949-B2
priorityDate 2003-11-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4341785-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009312357-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009082558-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4557866-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009028940-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7045620-B2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57507833
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393946
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16218600
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135783056
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14455022
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1533
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6251
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23429
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226413300
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135736016
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID20055249
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14878
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57507834
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226402238
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID453
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226421742
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID221068
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID72111
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226421741
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128851138
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393819
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393724
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54676860
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226397123
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393714
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226397122
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226495048
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57461352
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID107428
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393712
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394818
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226495047
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3423265
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136301963
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24699
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226520047
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57199466
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226520046
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6436173
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396472

Total number of triples: 67.